Articles Tagged With:
-
Empowered Relief vs. CBT vs. Health Education for Low Back Pain
This randomized clinical trial involving adults with chronic low back pain demonstrates that a single session of a pain management class, when compared to a full course of cognitive behavioral therapy, yields noninferior (clinically on par) outcomes in pain catastrophizing and several other measures at the three-month follow-up.
-
Double Trouble: Vaccines Lag, Virulent Mpox Clade 1 Spreads
The Centers for Disease Control and Prevention has released two health advisory alerts only a week apart, one dealing with the “urgent need” to vaccinate people for seasonal respiratory viruses; the second warning that a virulent type of mpox (monkeypox) virus is spreading in Africa.
-
The IP Role in Sepsis
The Centers for Disease Control and Prevention has issued core elements for hospital sepsis programs, calling for a multidisciplinary team to prevent, detect, and treat these life-threatening systemic breakdowns.
-
MRSA: Isolation and Contact Precautions Still Needed?
The authors of a new study question the merits of isolation and contact precautions for patients with methicillin-resistant Staphylococcus aureus.
-
Pandemic Raises Spectre of Bioterror
The three-year viral storm of COVID-19 circling the globe and killing millions of people has left a lingering question: Has the wholesale disruption and devastation of SARS-CoV-2 made biological pathogens a more compelling and/or attainable goal by bioterrorists?
-
The Seeker: Infection Control Doctor Takes the Road Less Traveled
Meet Leighann Parkes, MD, FRCPC, medical officer for infection prevention and control at McGill University in Montreal, who took a decidedly circuitous route to understanding and preventing infections.
-
Comeback: IPs Rally to Cut Infections Post-Pandemic
Infection preventionists and colleagues struggled against a global pandemic for more than two years in apparent futility, watching healthcare-associated infections (HAIs) increase despite their best efforts. Their perseverance paid off. HAIs fell in 2022 and signs look favorable thus far for 2023, the Centers for Disease Control and Prevention reports.
-
The Many Controversies of Cannabidiol
Current trends in cannabinoid research, federal and state cannabis legislation, multi-sourced information, as well as misinformation, all drive consumer interest in cannabidiol (CBD). With the increased use of CBD products, increased incidents of poisonings are being reported. With confusion on policy, on potential benefits and harms, and on long-term chronic effects often seen with excessive use, determining the facts is increasingly problematic for healthcare practitioners and consumers. These issues prioritize the need for clinicians, especially in primary care, to stay current on developments related to CBD and other cannabinoids.
-
Higher Mortality for Neurosurgery Patients with Pre-Existing DNRs
Neurosurgeons at University of Rochester Medicine observed that patients with pre-existing do-not-resuscitate (DNR) orders receiving cranial neurosurgery tended to have poor outcomes. To see if their clinical observations were reflected in actual data, the neurosurgeons analyzed 30,384 patients who underwent cranial neurosurgery in 2018-2020.
-
Audio Assistance Improves Minorities’ Willingness to Participate in Research
Audio-assisted informed consent forms significantly improved the willingness of a sample of primarily African American patients to participate in a mock clinical trial.